Olga Rajas

2.3k total citations
44 papers, 1.1k citations indexed

About

Olga Rajas is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Olga Rajas has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Olga Rajas's work include Pneumonia and Respiratory Infections (28 papers), Respiratory viral infections research (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Olga Rajas is often cited by papers focused on Pneumonia and Respiratory Infections (28 papers), Respiratory viral infections research (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Olga Rajas collaborates with scholars based in Spain and United States. Olga Rajas's co-authors include Javier Aspa, Felipe Rodrı́guez de Castro, Luis Borderías, José María Galván‐Román, José Blanquer, M. Luisa Briones, Jordi Solé‐Violán, Carlos Rodríguez‐Gallego, Jordi Rello and M. Isabel García-Laorden and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Olga Rajas

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Rajas Spain 20 689 311 210 165 94 44 1.1k
Adriana M. Rueda United States 14 631 0.9× 125 0.4× 84 0.4× 205 1.2× 62 0.7× 20 980
Pavel Chalupa Czechia 11 806 1.2× 149 0.5× 171 0.8× 138 0.8× 302 3.2× 40 1.3k
José Blanquer Spain 25 1.1k 1.6× 339 1.1× 245 1.2× 129 0.8× 349 3.7× 63 1.7k
Masahiro Kojika Japan 13 554 0.8× 127 0.4× 175 0.8× 66 0.4× 142 1.5× 39 825
Youenn Jouan France 16 261 0.4× 107 0.3× 229 1.1× 139 0.8× 150 1.6× 32 767
Mikael Gencay Switzerland 10 641 0.9× 251 0.8× 91 0.4× 44 0.3× 312 3.3× 16 1.0k
John S. Giuliano United States 15 356 0.5× 205 0.7× 82 0.4× 85 0.5× 59 0.6× 48 871
Martine Ferrandière France 14 283 0.4× 136 0.4× 95 0.5× 99 0.6× 102 1.1× 37 639
Erika Parmentier-Decrucq France 12 193 0.3× 118 0.4× 143 0.7× 149 0.9× 87 0.9× 33 751
Myung Goo Lee South Korea 15 205 0.3× 382 1.2× 117 0.6× 122 0.7× 34 0.4× 61 823

Countries citing papers authored by Olga Rajas

Since Specialization
Citations

This map shows the geographic impact of Olga Rajas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Rajas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Rajas more than expected).

Fields of papers citing papers by Olga Rajas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Rajas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Rajas. The network helps show where Olga Rajas may publish in the future.

Co-authorship network of co-authors of Olga Rajas

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Rajas. A scholar is included among the top collaborators of Olga Rajas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Rajas. Olga Rajas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solé‐Violán, Jordi, Elisa Hernández-Brito, Estefanía Herrera‐Ramos, et al.. (2020). Challenges in understanding host genetics and severity of community-acquired pneumonia. ERJ Open Research. 7(1). 745–2020.
2.
Hernández-Brito, Elisa, Carmen Muñoz‐Almagro, Íñigo Rúa‐Figueroa, et al.. (2019). Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway. Journal of Clinical Immunology. 40(1). 203–210. 15 indexed citations
3.
Curbelo, José, Olga Rajas, José María Galván‐Román, et al.. (2019). Estudio del porcentaje de neutrófilos y el cociente de neutrófilos-linfocitos como marcadores pronósticos en pacientes hospitalizados por neumonía adquirida en la comunidad. Archivos de Bronconeumología. 55(9). 472–477. 18 indexed citations
4.
Curbelo, José, José María Galván‐Román, Olga Rajas, et al.. (2017). Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLoS ONE. 12(3). e0173947–e0173947. 119 indexed citations
5.
Rosa, David de la, Miguel Ángel Martínez‐García, Rosa Girón, et al.. (2017). Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry. PLoS ONE. 12(5). e0177931–e0177931. 18 indexed citations
6.
Molinos, Luis, Rafael Zalacaín, Rosario Menéndez, et al.. (2015). Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia. Annals of the American Thoracic Society. 12(10). 1482–1489. 41 indexed citations
7.
Galván‐Román, José María, Olga Rajas, & Javier Aspa. (2015). Revisión sobre las infecciones no bacterianas del aparato respiratorio: neumonías víricas. Archivos de Bronconeumología. 51(11). 590–597. 31 indexed citations
8.
Rajas, Olga, José María Galván‐Román, José Curbelo, et al.. (2014). The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers. BMC Pulmonary Medicine. 14(1). 197–197. 7 indexed citations
9.
Menéndez, Rosario, Antoní Torres, Soledad Reyes, et al.. (2012). Compliance with Guidelines-Recommended Processes in Pneumonia: Impact of Health Status and Initial Signs. PLoS ONE. 7(5). e37570–e37570. 9 indexed citations
10.
García-Laorden, M. Isabel, Felipe Rodrı́guez de Castro, Jordi Solé‐Violán, et al.. (2012). The role of mannose-binding lectin in pneumococcal infection. European Respiratory Journal. 41(1). 131–139. 33 indexed citations
11.
Solé‐Violán, Jordi, M. Isabel García-Laorden, Felipe Rodrı́guez de Castro, et al.. (2011). The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia*. Critical Care Medicine. 39(6). 1388–1393. 38 indexed citations
12.
Martín‐Loeches, Ignacio, Jordi Solé‐Violán, Felipe Rodrı́guez de Castro, et al.. (2011). Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia. Intensive Care Medicine. 38(2). 256–262. 53 indexed citations
13.
Castro, Felipe Rodrı́guez de, Jordi Solé‐Violán, Olga Rajas, et al.. (2011). Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study. Critical Care. 15(1). R57–R57. 40 indexed citations
14.
Blanquer, José, Javier Aspa, Antonio Anzueto, et al.. (2011). Normativa SEPAR: neumonía nosocomial. Archivos de Bronconeumología. 47(10). 510–520. 19 indexed citations
15.
Blanquer, José, Javier Aspa, Antonio Anzueto, et al.. (2011). SEPAR Guidelines for Nosocomial Pneumonia. Archivos de Bronconeumología. 47(10). 510–520. 13 indexed citations
16.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2008). Risk Factors for Multidrug-Resistant Pneumococcal Pneumonia. Infectious Diseases in Clinical Practice. 16(6). 368–375.
17.
García-Laorden, M. Isabel, Jordi Solé‐Violán, Felipe Rodrı́guez de Castro, et al.. (2008). Mannose-binding lectin and mannose-binding lectin–associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. Journal of Allergy and Clinical Immunology. 122(2). 368–374.e2. 92 indexed citations
18.
Aspa, Javier, Olga Rajas, & Felipe Rodrı́guez de Castro. (2008). Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opinion on Pharmacotherapy. 9(2). 229–241. 29 indexed citations
19.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2006). Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. European Respiratory Journal. 27(5). 1010–1019. 62 indexed citations
20.
Aspa, Javier, Olga Rajas, Felipe Rodrı́guez de Castro, et al.. (2004). Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors. Clinical Infectious Diseases. 38(6). 787–798. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana M. Rueda Breakdown of academic impact, for papers by Pavel Chalupa Breakdown of academic impact, for papers by José Blanquer Breakdown of academic impact, for papers by Masahiro Kojika Breakdown of academic impact, for papers by Youenn Jouan Breakdown of academic impact, for papers by Mikael Gencay Breakdown of academic impact, for papers by John S. Giuliano Breakdown of academic impact, for papers by Martine Ferrandière Breakdown of academic impact, for papers by Erika Parmentier-Decrucq Breakdown of academic impact, for papers by Myung Goo Lee
Rankless by CCL
2026